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Abstract
Background: There is evidence to support that the number of self-reported symptoms is a strong predictor of
health outcomes. In studies examining the link between symptoms and functional status, focus has traditionally
been on individual symptoms or specific groups of symptoms. We aim to identify associations between the
number of self-reported symptoms and functional status.
Methods: A questionnaire was sent to people in seven age groups (N = 3227) in Ullensaker municipality in
Southern Norway. The Standardised Nordic Questionnaire and the Subjective Health Complaints Inventory were
used to record 10 musculoskeletal symptoms and 13 non-musculoskeletal symptoms, respectively. Four
COOP-WONCA charts were used to measure functional status.
Results: We found a strong linear association between the number of self-reported symptoms and functional
status. The number of symptoms explained 39.2% of the variance in functional status after adjusting for the effects
of age and sex. Including individual symptoms instead of only the number of symptoms made little difference to
the effect of musculoskeletal pain but affected the influence of non-muscular symptoms. Including even minor
problems captured substantially more of the variance in functional status than including only serious problems.
Conclusions: The strong association between the number of symptoms and functional status, irrespective of type
of symptom, might indicate that the symptoms share some common characteristics. The simple act of counting
symptoms may provide an approach to study the relationships between health and function in population studies
and might be valuable in research on medically unexplained conditions.
Keywords: Functional status, Medically unexplained symptoms, Number of symptoms, Population study,
Symptom reporting
Background
Health complaints are frequently reported in the general
population, but the prevalence rates vary between
studies. One population study showed that about 80% of
individuals experience one or more symptoms in any
given month [1]. In another study, 96% of people
reported at least one subjective health complaint during
the previous four weeks; musculoskeletal symptoms
being the most frequent complaint mentioned [2]. The
size of the “symptom iceberg” in the UK has been
explored in a recent article, describing the prevalence of
25 different symptoms in relation to individual charac-
teristics and chronic conditions [3]. In this study, the
mean number of symptoms experienced in the previous
two weeks was 3.7. However, an estimate of only one
in four individuals seeks medical attention for their
symptoms [4].
Evidence supports that the number of self-reported
symptoms are strongly associated with decrement in
functional status. In general population based data, the
number of somatic symptoms at baseline has been found
to be a clinically meaningful predictor of future health
status [5-7]. In clinical samples, a marked decline in
functional ability has been associated with an increasing
number of somatic symptoms [8,9], and patients report-
ing multiple somatic symptoms had worse functional
ability at all time points as compared to patients with
fewer symptoms [10]. In previous papers from the Ullen-
saker Population Study, the number of musculoskeletal
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pain sites explained a substantial part of the variance in
functional ability and was a strong predictor of future
disability pensioning [11,12]. The number of pain sites
was more important than the localization of pain, and
was strongly associated with the number of non-
musculoskeletal symptoms [13].
Patients reporting several symptoms often represent a
challenge to the health care system. In recent years,
there has been increasing focus on so-called “medically
unexplained symptoms” (MUS), for which there is no
evident medical explanation and which are seemingly
unrelated to organic disease. In a study in primary care,
slightly more than half of the somatic symptoms pre-
sented were classified as physical in aetiology, more than
one-third were rated as “idiopathic”, and 10% as “psychi-
atric” [14]. Other researchers estimate that 30–75% of
physical symptoms lack a clear-cut organic cause, even
after extensive diagnostic testing [8]. It has been pro-
posed to abandon the identification of MUS, as report-
ing multiple explained symptoms and MUS have similar
health outcomes. Hence, research on multisymptomatol-
ogy might be increasingly important, as this term may
cover the phenomenon of MUS and somatisation in fu-
ture definitions and classifications [7,15-17].
In this article, we describe symptom reporting in a
general population by presenting the number of symp-
toms reported and their association with functional sta-
tus. We compare how the number of pain sites, the
number of non-musculoskeletal symptoms and the total
symptom load are associated with functional status mea-
sures. In addition, we explore whether knowing which
symptoms are reported exceeds the symptom count in
explaining the variance of functional status.
Methods
Ullensaker is a municipality situated 40 km northeast of
Oslo, the capital of Norway, and had 23,700 inhabitants
in 2004. As part of a cohort study on musculoskeletal
complaints starting in 1990, we sent a postal question-
naire to all inhabitants in the following birth cohorts in
2004: 1918–20, 1928–30, 1938–40, 1948–50, 1958–60,
1968–70, and 1978–80. One reminder was sent to
the non-responders. The study was approved by the
Regional Committee for Medical and Health Research
Ethics.
Musculoskeletal symptoms were assessed using the
Standardised Nordic Questionnaire (SNQ) [18]. The
respondents were asked to report whether they had
experienced pain or discomfort in the following 10 areas
during the previous week: head, neck, shoulder, elbow,
hand/wrist, upper back, lower back, hip, knee and ankle/
foot (optional answers: yes/no). The regions were illu-
strated on a body manikin. A simple sum score, the
number of pain sites (NPS) was constructed, ranging
from 0 to 10.
Non-musculoskeletal symptoms were measured by a
selection of 13 symptoms from the Subjective Health
Complaints Inventory (SHC), which comprises 29 com-
mon health complaints [19]. The following 13 symp-
toms were included: palpitations, chest pain, breathing
difficulties, heartburn, stomach discomfort, diarrhoea,
constipation, eczema, tiredness, dizziness, anxiety, depres-
sion and sleep problems. Respondents were asked to
grade the intensity of each complaint experienced over
the past month on a four-point scale: not at all both-
ered, a little bothered, somewhat bothered and severely
bothered. To correspond to “pain or discomfort” in the
musculoskeletal symptom question, the answers were
dichotomized into “not at all” (scored 0) vs. all other
responses (scored 1), which gave an overall sum score
of the number of non-musculoskeletal symptoms (NN-
MS) of 0–13.
Functional status was recorded using the Norwegian
version of COOP-WONCA charts [20]. In this study, we
used four charts: physical fitness, feelings, daily activities
and social activities. The participants were asked to rate
their situation during the previous two weeks on five-
point scales. Each level was illustrated pictorially, nu-
merically and in writing. A score of 1 indicated no prob-
lem or limitation and 5 indicated maximal limitation. In
this analysis, we included the four different dimensions
and the sum score, which ranged from 4 to 20.
Statistical analyses
Individuals who did not answer any symptom questions
were excluded. We assumed that those who answered
“yes” or “no” to at least one question about musculoskel-
etal symptoms meant to answer “no” to the questions
left unanswered. Corresponding imputation procedures
were performed for non-musculoskeletal symptoms. A
full account of imputation procedures has been docu-
mented elsewhere [13]. For functional status, those who
had responded to at least one of the six COOP WONCA
charts were assumed to have responded “no limitations”
on the remaining charts if left blank.
Descriptive statistics in the form of means and percen-
tages, with 95% confidence intervals (CIs), were used to
describe self-reported symptoms. We performed linear
regression analyses, after checking for collinearity
between the variables, all using the sum score of COOP-
WONCA as the dependent variable. Independent
variables in the different models were: Model I: NPS (the
number of pain sites); Model II: NN-MS (the number of
non-musculoskeletal symptoms); Model III: The total
symptom load (NPS + NN-MS); Model IV: All the 10
individual musculoskeletal symptoms; Model V: All the
13 individual non-musculoskeletal symptoms; Model VI:
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All the individual 23 musculoskeletal and non-
musculoskeletal symptoms. All variables were stratified
by sex. We present the change in determination coeffi-
cient (ΔR2) for each component in the model, i.e. the
contribution of explained variance by each variable; the
unstandardised beta-value with 95% CI, and the standar-
dised beta-value. In addition we performed analyses to
obtain the measurement of fit Bayesian Information Cri-
terion (BIC) to compare the six symptom models.
The individual symptoms were modelled individually
after controlling for age, sex (Model A) and adjustment
for the 22 other symptoms in addition to age and sex
(Model B).
Finally, we performed linear regression analyses mod-
elling the individual non-musculoskeletal symptoms and
NN-MS in functional status/COOP-WONCA, where the
cut-off for dichotomization varied: alternative 1: code 0:
“not at all” + “a little” or code 1: “some” + “severe”; alter-
native 2: code 0: “not at all” + “a little” + “some” or code
1: “severe”.
Analyses were performed using SPSS for Windows
(version 16).
Results
The questionnaire was sent to 6105 persons, and after
one reminder, 3325 individuals responded, giving a re-
sponse rate of 54.4%. Individuals who had not answered
any of the symptom questions were excluded (N = 98) as
well as individuals with missing values for age, sex or
any of the COOP/WONCA scales (N = 20), resulting in
a final sample of 3207 individuals (52.4% of the original
sample size). Of the respondents, 54.9% were women.
The mean age of the sample was 47.5 (SD 14.9), women
47.2 (SD 15.0) and men 47.9 (SD14.7), both with a range
from 24–86 years. An account on non-responders
has been documented elsewhere [13]. Non-responders
were mostly among men, and in the youngest and oldest
age-groups.
A mean number of 2.3 (95% CI: 2.2-2.4) musculoskel-
etal symptoms was reported (women 2.8 (2.6-2.9) and
men 1.8 (1.7-1.9) symptoms). The mean number of non-
musculoskeletal symptoms was 3.7 (3.6-3.8) women 4.0
(3.9-4.1) and men 3.3 (3.2-3.4). The mean total symptom
load (NPS + NN-MS) was 6.0 (5.9-6.2): 6.7 (6.5-7.0) in
women and 5.1 (4.9-5.5) in men. No individual reported
all 23 symptoms. Figure 1 shows the prevalence of the
number of symptoms by sex. A total of 22.6% reported
10 symptoms or more (95% CI: 21.2–24.0), 27.8% among
women (25.8–30.0), and 16% among men (14.4–18.3).
The number of functional problems increased linearly
with an increase in NPS, NN-MS and total symptom
load (NPS + NN-MS); there was no threshold or level-
ling out (Figure 2). Figure 3 shows how the four dimen-
sions of functional ability increased from minor, almost
no restrictions, to “substantial” restrictions as the num-
ber of symptoms increased from 0 to 22.
Table 1 shows the relationship between the number of
symptoms and functional status. NPS (Model I)
explained 24.9% of the variance in functional status,
whereas the individual musculoskeletal symptoms
(model IV) explained only slightly more (26.0%), after
adjusting for the effects of age and sex. When it comes
to the non-musculoskeletal symptoms, NN-MS had an
explanatory power in functional status of 35.0% (Model
II), whereas the individual non-musculoskeletal symp-
toms (Model V) had a substantially higher explanatory
power (42.4%). Modelling the total symptom load (NPS
+ NN-MS) (Model III) rendered 39.2% explained vari-
ance in functional status, whereas all 23 individual
symptoms explained 48.2% (Model VI). The explanatory
power was somewhat smaller for men in all the six mod-
els (data not shown). These findings are consistent with
the BIC-analyses, where the three models including
Figure 1 Number of symptoms reported in an adult population
(percentage), stratified by sex.
Figure 2 Functional status reported in an adult population in
respondents with different numbers of symptoms. Footnote:
Functional status is measured on four COOP-WONCA scales: physical
fitness, feelings, daily activities, social activities, with a total range
4-20. Symptoms are grouped into Number of pain sites (0-10);
Number of non-musculoskeletal symptoms (0-13) and total number
of symptoms (0-23).
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individual symptoms had the lowest BIC, and hence were
ranged as having the best fit to the data, compared to the
models with number of symptoms (data not shown).
Table 2 shows the extent to which the 23 single symp-
toms explained the variance in functional status after
age and sex adjustment (Model A). Depression and
anxiety had a much higher explanatory power than
the remaining symptoms, explaining 28.1% and 25.9%
of the variance in functional status, respectively.
The explanatory power diminished substantially or dis-
appeared after controlling for the remaining symptoms,
although some of the individual symptoms remained
significant (Model B).
We used the SNQ to ask about “pain or discomfort”
without any grading of severity. Similarly, for the non-
musculoskeletal symptoms, we included reports of being
“a little bothered” by the symptom in question. When
only those with at least “some problems” were included,
the mean number of non-musculoskeletal symptoms
was 1.5 (95% CI 1.4–1.5), and the explanatory power in
functional ability was only slightly increased as opposed
to including all levels of severity (36.1 vs. 35.0%). Includ-
ing only those reporting “severe problems”, however,
reduced the explanatory power in functional ability to
21.5% after adjusting for the effects of age and sex.
Discussion
A substantial proportion of the population reports a var-
iety of symptoms. We have documented a strong linear
association between number of self-reported symptoms
and functional status. Including the individual symptoms
instead of the number of symptoms made little differ-
ence to the influence of musculoskeletal pain, but
affected the influence of non-musculoskeletal symptoms
more. The influence of single symptoms in explaining
the variance in functional ability decreased after control-
ling for the total burden of other symptoms. Including
even minor problems captured substantially more of the
association with function compared to including only
serious problems.
Methods
Even though we used media to motivate participation,
the response rate was modest. The Ullensaker Popula-
tion Study has used the SNQ to measure musculoskel-
etal symptoms since the start in 1990. When we decided
to also include non-musculoskeletal symptoms, we
chose to use a modified version of a validated instru-
ment, the SHC. Hence, there is a temporal mismatch be-
tween the two instruments, the one-week window in the
SNQ and the 30-day window in the SHC. Consequently,
our results are not a consistent measurement of the total
symptom count for a defined period. The two-week win-
dow in the WONCA charts adds to the mismatch. Be-
cause our interest is mainly the association between
symptoms and other variables, and because the associa-
tions were so strong, our conclusions should still be
valid despite the low response rate and methodological
shortcomings.
The results from this study might partly reflect report-
ing behaviour. Some persons might tend to report any
discomfort, whereas others do not mention minor
Figure 3 Functional status reported in an adult population as
the means of four COOP/WONCA charts in respondents with
different numbers of symptoms.
Table 1 Functional status in an adult population, as a function of individual symptoms and the number symptoms
reported
ΔR2 β(95%CI) Stand. Beta BIC
Model I NPS 0.249 0.69 (0.65-0.73) 0.51 15488
Model II NN-MS 0.350 0.68 (0.65-0.71) 0.60 14963
Model III NPS + NN-MS 0.392 0.45(0.43-0.46) 0.64 14796
Model IV Ind. musculoskeletal symptoms 0.260 Ind. Ind. 15450
Model V Ind. non-musculoskeletal symptoms 0.424 Ind. Ind. 14540
Model VI Ind. musculoskeletal + non-musculoskeletal symptoms 0.482 Ind. Ind. 14224
Footnote: Functional ability is measured on four COOP-WONCA scales: physical fitness, feelings, daily activities, social activities. Symptoms are grouped in NPS
(Number of pain sites), NN-MS (Number of non-musculoskeletal symptoms). ΔR2: Change in correlation coefficients contributed by the variable (removing effect of
age); β: unstandardized regression coefficient with CI (Confidence interval); Stand. beta: Standardised beta values converted to the same scale for all variables. BIC
(Bayesian Information Criterion): a measure of fit applicable for model selection, penalising for the number of variables in the model (low value indicates better
fit). Ind.: each component has an individual value.
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discomfort. However, we have previously shown that
the number of pain sites strongly predicts future dis-
ability pensioning [12]. Non-responders in this study
were mostly among groups reporting the least symp-
toms (men and youngest and oldest age groups), indi-
cating that our findings might overestimate symptom
prevalences.
Results
Although single symptoms are important in the clinical
setting, the number of symptoms seems to be an import-
ant dimension in population studies. This phenomenon
has attracted increasing attention in recent years
[3,11,12,21]. However, different studies have used differ-
ent methods including the recording of symptoms,
symptom definitions and time windows.
There is reason to believe that patients do not re-
port in the same way during a clinical consultation
and that health professionals do not know the full
spectrum of symptoms experienced by their patients.
We included minor problems, which are seldom
presented in medical encounters, as well as more ser-
ious problems, which would be presented in medical
encounters; hence, our study presents the whole ice-
berg of symptoms.
It seems that the total burden of symptoms is an im-
portant dimension of functional ability. We are the first
to show that functional ability decreases linearly and
does not level out throughout the whole range of symp-
toms, without distinguishing between musculoskeletal or
non-musculoskeletal symptoms, or between mental and
somatic symptoms. Patients with a number of controver-
sial diagnoses, such as chronic fatigue syndrome, irrit-
able bowel syndrome or fibromyalgia, or patients with
the overriding concept of medically unexplained symp-
toms, all report many symptoms and were probably
included among those reporting the most symptoms in
our study.
A UK-wide population study of a similar size and in-
cluding a similar number of symptoms (25 vs. the 23 in
this study), found a mean of 3.7 symptoms among
respondents [3], a substantially lower mean than our 6.0.
Table 2 Functional status in an adult population, as a function of separate symptoms
Model A Model B
Symptom ΔR2 β(95% CI) P-value St. β ΔR2 β(95% CI) P-value St. β
Head 0.076 1.94 (1.72–2.16) <0.001 0.28 0.001 0.23 (0.04–0.41) 0.017 0.033
Neck 0.088 2.01 (1.79–2.22) <0.001 0.30 <0.001 −0.024 (−0.23–-0.18) 0.823 −0.004
Shoulders 0.089 2.03 (1.81–2.24) <0.001 0.30 <0.001 0.075(−0.13–0.28) 0.296 0.011
Elbows 0.047 2.34 (1.99–2.68) <0.001 0.22 0.001 0.37 (0.092–0.64) 0.009 0.034
Wrists/hands 0.069 2.23 (1.96–2.50) <0.001 0.27 0.001 0.28 (0.053–0.51) 0.016 0.034
Upper back 0.117 2.83 (2.58–3.09) <0.001 0.35 0.005 0.67 (0.45–0.89) <0.001 0.082
Lower back 0.110 2.24 (2.03–2.45) <0.001 0.33 0.007 0.65 (0.47–0.82) <0.001 0.096
Hips 0.080 2.49 (2.21–2.77) <0.001 0.29 0.004 0.60 (0.37–0.82) <0.001 0.070
Knees 0.074 2.24 (1.98–2.51) <0.001 0.27 0.005 0.65 (0.44–0.86) <0.001 0.079
Ankles/feet 0.065 2.27 (1.98–2.55) <0.001 0.26 0.001 0.36 (0.12–0.59) 0.03 0.041
Palpitations 0.062 1.98 (1.72–2.23) <0.001 0.25 <0.001 0.084 (−0.12–0.29) 0.411 0.011
Chest pain 0.069 2.21(1.94–2.48) <0.001 0.26 <0.001 0.00 (−0.22–0.23) 0.41 0.00
Breathing difficulties 0.107 2.74 (2.48–3.00) <0.001 0.33 0.005 0.69 (0.47–0.91) <0.001 0.083
Heartburn 0.035 1.28 (1.05–1.50) <0.001 0.19 <0.001 −0.024 (−0.20–0.15) 0.791 −0.003
Stomach discomfort 0.079 2.15 (1.91–2.40) <0.001 0.28 0.001 0.25 (−0.045–0.457) 0.017 0.033
Diarrhoea 0.036 1.35(1.12–1.58) <0.001 0.19 0.001 0.19 (0.018–0.36) 0.030 0.027
Constipation 0.039 1.89 (1.58–2.20) <0.001 0.20 0.001 0.23 (0.00–0.46) 0.050 0.025
Eczema 0.011 0.85 (0.58–1.12) <0.001 0.10 <0.001 0.021 (−0.17–0.21) 0.212 0.003
Tiredness 0.101 2.12 (1.91–2.33) <0.001 0.32 0.001 0.23 (0.050–0.402) 0.012 0.034
Dizziness 0.103 2.31 (2.08–2.53) <0.001 0.32 0.001 0.28 (0.09–0.470) 0.004 0.040
Anxiety 0.259 3.94 (2.73–4.16) <0.001 0.51 0.026 1.60 (1.37–1.83) <0.001 0.207
Depression 0.281 3.61 (3.42–3.79) <0.001 0.54 0.035 1.65 (1.45–1.85) <0.001 0.245
Sleep problems 0.133 2.37 (2.18–2.58) <0.001 0.37 0.010 0.72 (0.56–-0.89) <0.001 0.113
Footnote: Functional status is measured on four COOP-WONCA scales: physical fitness, feelings, daily activities, social activities, and the dependent variable in all
analyses is sum score of these charts. ΔR2: the change in R2 (multiple correlation coefficient) accounted for by the variable; β: unstandardised regression
coefficient; CI: Confidence interval; St.β:Standardised β value. Model A: Linear regression analysis performed with individual symptoms, controlling for age and sex.
Model B: Multiple regression model controlling for all other symptoms, in addition to age and sex.
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Although methodological differences might explain part
of the difference, Norwegians regularly report many
symptoms in health examination studies. A European
study of chronic pain showed that Norwegians were on
top with a prevalence of 30%, compared to 13% of the
UK responders [22].
We found that the 23 individual symptoms explained
almost half of the variance in functional status, which
must be considered a substantial contribution. The ex-
planatory powers of the models in Table 1, as measured
by ΔR 2, are not directly comparable. The models in-
cluding the individual symptoms have a higher number
of variables which in itself renders higher R2. However,
the findings were also supported by use of another
measure of fit, BIC, which showed the same ranking of
the models (Table 1).
Although the number of symptoms does not com-
pletely capture the explanatory power of individual
symptoms, it seems that the number may be an accept-
able proxy and provide substantial information in a
population setting. Including the number of symptoms
instead of individual symptoms may provide statistical
advantage in smaller population sizes, such as in clinical
settings.
All individual symptoms contributed to explaining the
variance in functional status, but only a few remained
significant after adjusting for the total symptom load.
This is not surprising, since the individual symptoms are
interrelated.
We found that anxiety and depression were symptoms
that had substantially higher explanatory power in func-
tional status than other symptoms. This effect was
reduced, but still statistically significant, after controlling
for report of remaining symptoms. Other studies have
found a strong association between number of symp-
toms and psychiatric morbidity [1,8,23,24]. One study
has documented that the number of somatic symptoms
and anxiety/depression independently account for im-
pairment in health related quality of life [25]. However,
we propose that a differentiation between mental and
somatic symptoms should be avoided in future generic
epidemiological studies.
In this paper we have looked at associations between
symptoms and functional status, not causal relationships.
Exploratory analyses indicate that socioeconomic status
(measured as marrital status, educational level and em-
ployment status in our study) contribute to approxi-
mately 16% of the variance in functional status if
included in the models in Table 1.
The strong association between the number of symp-
toms and functional status might indicate that the symp-
toms share some common characteristics, regardless of
whether these are mental or somatic. There is a need for
a common instrument to explore the phenomenon of
symptom reporting in the population to make a com-
parison of studies easier.
Conclusion
The simple act of counting symptoms provides an ap-
proach for population-based studies and might even be
valuable in research on medically unexplained symp-
toms. Whether the method of counting symptoms will
have consequences for future clinical work and in what
manner remains to be seen.
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